New hope for pancreatic cancer: targeted drug plus chemo enters trials
NCT ID NCT07444541
First seen Mar 18, 2026 · Last updated May 15, 2026 · Updated 7 times
Summary
This study tests a new drug called ANO31905 combined with standard chemotherapy as a first treatment for people with a specific type of advanced pancreatic cancer (CLDN18.2-positive). About 84 adults with cancer that cannot be removed by surgery or has spread will take part. The goal is to see if the combination is safe and shrinks tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.